Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
BMC Cancer, 2018 Background To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence.
Ivana Burazor +9 more
doaj +2 more sources
Contrast-enhanced echocardiographic diagnosis of benign and malignant cardiac tumors and its correlation with pathology [PDF]
Frontiers in Cardiovascular Medicine, 2023 BackgroundThis study aimed to explore the diagnostic value of contrast-enhanced echocardiography (CEE) in benign and malignant cardiac tumors and detect the correlation of CEE parameters and immunohistochemistry (IHC) markers.MethodsThe data of 44 ...
Zihao Yang +6 more
doaj +2 more sources
Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study [PDF]
Journal of Cardiothoracic Surgery, 2017 BackgroundThe frequency of primary cardiac tumors is rare at about 0.3% by autopsy. Our objective was to investigate the characteristics and locations of cardiac tumors and to provide a prognostic analysis in our hospital.MethodsWe collected data on 95 ...
Natsumi Nomoto +9 more
semanticscholar +2 more sources
Clinical presentations, diagnosis, and management of arrhythmias associated with cardiac tumors
Journal of Arrhythmia, 2018 Cardiac tumors are a rare cause of arrhythmias in clinical practice. They can cause a broad spectrum of arrhythmias, from low‐grade ectopics to incessant ventricular tachycardias, including sudden cardiac arrest. Both primary and secondary cardiac tumors
Shenthar Jayaprakash
doaj +2 more sources
Reduced Risk of All-Cause, Cancer-, and Cardiovascular Disease-Related Mortality among Patients with Primary Malignant Cardiac Tumors Receiving Chemotherapy in the United States [PDF]
Current Oncology, 2023 Primary malignant cardiac tumors (PMCTs) are rare but lethal neoplasms. There are limited evidence-based treatment guidelines for PMCTs. We evaluated the relation of chemotherapy with mortality outcomes in patients with PMCTs in the United States.
Duke Appiah +4 more
doaj +2 more sources
Survival and analysis of prognostic factors for primary malignant cardiac tumors based on the SEER database. [PDF]
J Cancer Res Clin Oncol, 2023 Chen X +6 more
europepmc +3 more sources
Fetal Primary Cardiac Tumors During Perinatal Period
Pediatrics and Neonatology, 2017 Fetal primary cardiac tumors are rare, but they may cause complications, which are sometimes life threatening, including arrhythmias, hydrops fetalis, ventricular outflow/inflow obstruction, cardiac failure, and even sudden death.
Shi-Min Yuan
doaj +2 more sources
Cardiac tumors: echo assessment
Echo Research and Practice, 2016 Cardiac tumors are exceedingly rare (0.001–0.03% in most autopsy series). They can be present anywhere within the heart and can be attached to any surface or be embedded in the myocardium or pericardial space.
Rekha Mankad MD, Joerg Herrmann MD
doaj +2 more sources
Editorial: Editor’s challenge: Mohamed Rahouma - how can we optimize the management and treatment of cardiac tumors and cardiac complications of cancer? [PDF]
Frontiers in Oncology, 2023 Mohamed Rahouma +5 more
doaj +2 more sources
ISRN Oncology, 2011 Cardiac tumors represent a relatively rare, yet challenging diagnosis. Secondary tumors are far more frequent than primary tumors of the heart. The majority of primary cardiac tumors is benign in origin, with primary malignant tumors accounting for 25% of cases.
Paraskevaidis, Ioannis A. +3 more
openaire +3 more sources